文献速递儿童青少年精神心境障碍

氯化锂体外治疗可挽救WDFY3单倍剂量不足导致的神经元表型

Lithium chloride in vitro treatment shows potential to rescue the neuronal phenotype caused by WDFY3 haploinsufficiency.
PubMed 文献 · Mol Psychiatry · 2026-09-27

基于迄今最大规模WDFY3功能缺失变异队列(n=32),研究定义了一种以神经精神特征(含孤独症和ADHD)、轻至中度神经发育迟缓和脑生长异常为特征的孟德尔遗传病。体外SH-SY5Y敲低和Wdfy3单倍剂量不足小鼠模型显示蛋白聚集体清除受损、p62降低及MAPK/ERK1/2和WNT/β-catenin信号失调。LiCl可显著增加WDFY3表达并改善Wdfy3单倍剂量不足神经元的神经突分支能力,提示其可能成为WDFY3功能缺失患者的潜在治疗策略。

要点

  • WDFY3功能缺失变异定义一种以孤独症、ADHD和神经发育迟缓为特征的孟德尔遗传病。
  • WDFY3敲低损害蛋白聚集体清除、降低p62并失调MAPK/ERK1/2和WNT/β-catenin信号。
  • LiCl体外处理增加WDFY3表达并改善Wdfy3单倍剂量不足神经元的神经突分支。

核心结论

  • WDFY3功能缺失导致以神经精神特征、神经发育迟缓和脑生长异常为表现的孟德尔遗传病。
  • LiCl体外处理可增加WDFY3表达并改善Wdfy3单倍剂量不足神经元的神经突分支能力。
  • LiCl可能作为WDFY3功能缺失患者的潜在治疗策略。

研究设计与样本

  • 基于迄今最大规模WDFY3功能缺失变异队列(n=32)进行综合表型分析。
  • 在人神经母细胞瘤细胞系SH-SY5Y中进行敲低实验,并使用Wdfy3单倍剂量不足小鼠模型。

主要发现

  • WDFY3敲低损害蛋白聚集体清除并降低泛素结合蛋白p62水平。
  • 转录组分析发现神经系统发育、神经元投射、MAPK/ERK1/2和WNT/β-catenin信号相关基因网络失调,并在蛋白水平确认。
  • 神经元细胞增殖增加(细胞计数及Ki-67和PCNA增殖标志物升高),而神经元细胞分化受损(神经突生长减少)。
  • β-catenin下调而GSK3B上调;LiCl通过抑制GSK3B激活WNT/β-catenin信号。
  • LiCl处理显著增加WDFY3表达,并改善Wdfy3单倍剂量不足神经元的神经突分支能力至野生型以上,但该效应似乎独立于WNT/β-catenin信号。

关键数值与推荐

  • WDFY3功能缺失变异队列n=32,表现为神经精神特征(含孤独症和ADHD)、轻至中度神经发育迟缓和脑生长异常(最常见巨头畸形,1例头围减小)。
  • WDFY3敲低后p62蛋白水平降低,β-catenin下调而GSK3B上调。
  • LiCl处理显著增加WDFY3表达,并改善Wdfy3单倍剂量不足神经元的神经突分支能力至野生型以上。

临床怎么用

  • 对WDFY3功能缺失变异患者应评估神经精神特征(含孤独症和ADHD)、神经发育迟缓和脑生长异常。
  • LiCl目前仅为体外和动物模型证据,尚未推荐用于WDFY3功能缺失患者的临床治疗。

局限性

  • 研究主要基于体外细胞系和动物模型,尚未在患者中验证LiCl的疗效和安全性。
  • LiCl改善神经突分支的效应似乎独立于WNT/β-catenin信号,具体机制未完全阐明。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

We provide a comprehensive phenotypic characterization of loss-of-function (LoF) variants in WDFY3 based on the largest cohort reported to date (n = 32). Our findings define a monogenic disorder marked by neuropsychiatric features (including autism and ADHD), mild to moderate neurodevelopmental delay, and variable brain growth - most commonly macrocephaly and in one case reduced head circumference. To investigate the effect of WDFY3 LoF we performed knockdown (KD) in the human neuroblastoma cell line SH-SY5Y and used a Wdfy3-haploinsufficient mouse model. WDFY3 KD impaired clearance of protein aggregates and decreased protein levels of the ubiquitin-binding protein p62. Transcriptomic analyses identified dysregulation in gene networks that are primarily involved in nervous system development, neuron projection, MAPK/ERK1/2, and WNT/β-catenin signaling. This was confirmed at protein level. Neuronal cell proliferation was increased, as evidenced by elevated cell counts and proliferation markers Ki-67 and PCNA. Conversely, neuronal cell differentiation was impaired, as indicated by reduced neurite outgrowth. We show that β-catenin is downregulated, while GSK3B is upregulated. LiCl activates WNT/β-catenin signaling by inhibiting GSK3B. We thus tested LiCl treatment, which significantly increased WDFY3 expression. Moreover, in vitro treatment improved the neurite branching capacity of Wdfy3-haploinsufficient neurons above the level of the wild type, although this specific effect appeared independent of WNT/β-catenin signaling. In sum, we expand on the phenotype related to WDFY3 LoF and provide insights into the pathophysiology using in vitro human and murine neuronal models. Our findings suggest that LiCl may serve as a potential therapeutic strategy for patients with WDFY3 LoF variants.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Paha MJ, Mustafa A, Tat L, et al. Lithium chloride in vitro treatment shows potential to rescue the neuronal phenotype caused by WDFY3 haploinsufficiency. Mol Psychiatry. 2026. PMID: 42800802. doi:10.1038/s41380-026-03844-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。